PHIO
Phio Pharmaceuticals Corp.$0.75-0.02 (-2.84%)Prev Close$0.77·MCap$13.1M·P/E—·Vol76.5K·Yield—
▲
Buys (12M)
14
$141.7K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$141.7K
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Phio Pharmaceuticals Corp. (PHIO) has been exclusively buying, with 14 insider purchases totaling $141.7K and 0 insider sales totaling $0.00. The most recent insider transaction was by Deming David H (director), who purchased $9.8K worth of shares on Nov 16, 2026. Phio Pharmaceuticals Corp. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $13.1M.
PHIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Deming David H | director | Buy | 12,000 | $0.82 | $9.8K | 61,800 |
| Nov 12, 2026 | Deming David H | director | Buy | 12,000 | $0.84 | $10.1K | 49,800+32% |
| Nov 10, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 25,000 | $0.82 | $20.5K | 789,871 |
| Nov 10, 2026 | Plott Ronald Todd | director | Buy | 18,300 | $0.83 | $15.2K | 60,300+44% |
| Sep 30, 2026 | Plott Ronald Todd | director | Buy | 10,000 | $1.04 | $10.3K | 42,000+31% |
| Sep 25, 2026 | BRADFORD PATRICIA A | director | Buy | 6,500 | $1.01 | $6.6K | 64,151 |
| Sep 23, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 2,000 | $1.03 | $2.1K | 364,871 |
| Sep 16, 2026 | BRADFORD PATRICIA A | director | Buy | 12,000 | $1.03 | $12.4K | 57,651+26% |
| Aug 20, 2026 | Plott Ronald Todd | director | Buy | 15,000 | $1.14 | $17.1K | 15,000 |
| Aug 19, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 10,000 | $1.06 | $10.6K | 431,421 |
| Jun 29, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 10,000 | $0.99 | $9.9K | 421,421 |
| Dec 23, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Buy | 5,000 | $1.02 | $5.1K | 0 |
| Nov 21, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Buy | 5,000 | $1.14 | $5.7K | 0 |
| Nov 18, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Buy | 5,000 | $1.27 | $6.3K | 0 |
| Sep 11, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Sell | 4,111 | $2.32 | $9.5K | 0 |
| Jun 10, 2025 | Bitterman Robert J | Chairman, Pres & CEO | Buy | 2,000 | $2.42 | $4.8K | 0 |
| Jun 10, 2025 | Ferrara Robert L | Director | Buy | 2,500 | $2.42 | $6.0K | 0 |
| Jun 9, 2025 | Bitterman Robert J | Chairman, Pres & CEO | Buy | 1,500 | $2.75 | $4.1K | 0 |
| May 23, 2025 | Bitterman Robert J | Chairman, Pres & CEO | Buy | 4,200 | $1.77 | $7.4K | 23,649 |
| May 21, 2025 | Ferrara Robert L | Director | Buy | 2,500 | $1.82 | $4.5K | 13,166 |
| Jun 11, 2024 | Bitterman Robert J | President & CEO | Buy | 1,000 | $0.74 | $740.00 | 20,990 |
| Jun 10, 2024 | Bitterman Robert J | President & CEO | Buy | 1,000 | $0.75 | $750.00 | 19,990 |
| Feb 27, 2024 | Bitterman Robert J | President & CEO | Buy | 2,500 | $0.91 | $2.3K | 18,990 |
| Jul 5, 2023 | Bitterman Robert J | President & CEO | Buy | 2,000 | $2.86 | $5.7K | 19,211 |
| Jun 15, 2023 | Ferrara Robert L | Director | Buy | 2,000 | $3.10 | $6.2K | 6,000+50% |
| Dec 15, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.39 | $780.00 | 74,541 |
| Dec 8, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.39 | $780.00 | 72,541 |
| Dec 6, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.43 | $860.00 | 70,541 |
| Dec 5, 2022 | Ferrara Robert L | Director | Buy | 5,000 | $0.41 | $2.0K | 30,000 |
| Nov 29, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,715 | $0.42 | $1.1K | 68,541 |
| Nov 28, 2022 | Ferrara Robert L | Director | Buy | 2,000 | $0.41 | $819.80 | 25,000 |
| Aug 17, 2021 | Dispersyn Gerrit | President & CEO | Buy | 6,000 | $1.63 | $9.8K | 95,281 |
| Mar 5, 2021 | Dispersyn Gerrit | President & CEO | Buy | 1,953 | $2.56 | $5.0K | 89,281 |
| Mar 3, 2021 | Dispersyn Gerrit | President & CEO | Buy | 2,500 | $3.03 | $7.6K | 87,328 |
| Mar 3, 2021 | Ferrara Robert L | Director | Buy | 682 | $3.15 | $2.1K | 13,000 |
PHIO Insider Buying Activity
The following table shows recent insider purchases of Phio Pharmaceuticals Corp. (PHIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Deming David H | director | Buy | 12,000 | $0.82 | $9.8K | 61,800 |
| Nov 12, 2026 | Deming David H | director | Buy | 12,000 | $0.84 | $10.1K | 49,800+32% |
| Nov 10, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 25,000 | $0.82 | $20.5K | 789,871 |
| Nov 10, 2026 | Plott Ronald Todd | director | Buy | 18,300 | $0.83 | $15.2K | 60,300+44% |
| Sep 30, 2026 | Plott Ronald Todd | director | Buy | 10,000 | $1.04 | $10.3K | 42,000+31% |
| Sep 25, 2026 | BRADFORD PATRICIA A | director | Buy | 6,500 | $1.01 | $6.6K | 64,151 |
| Sep 23, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 2,000 | $1.03 | $2.1K | 364,871 |
| Sep 16, 2026 | BRADFORD PATRICIA A | director | Buy | 12,000 | $1.03 | $12.4K | 57,651+26% |
| Aug 20, 2026 | Plott Ronald Todd | director | Buy | 15,000 | $1.14 | $17.1K | 15,000 |
| Aug 19, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 10,000 | $1.06 | $10.6K | 431,421 |
| Jun 29, 2026 | Bitterman Robert J | director, officer: Chairman, Pres. & CEO | Buy | 10,000 | $0.99 | $9.9K | 421,421 |
| Dec 23, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Buy | 5,000 | $1.02 | $5.1K | 0 |
| Nov 21, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Buy | 5,000 | $1.14 | $5.7K | 0 |
| Nov 18, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Buy | 5,000 | $1.27 | $6.3K | 0 |
| Jun 10, 2025 | Bitterman Robert J | Chairman, Pres & CEO | Buy | 2,000 | $2.42 | $4.8K | 0 |
| Jun 10, 2025 | Ferrara Robert L | Director | Buy | 2,500 | $2.42 | $6.0K | 0 |
| Jun 9, 2025 | Bitterman Robert J | Chairman, Pres & CEO | Buy | 1,500 | $2.75 | $4.1K | 0 |
| May 23, 2025 | Bitterman Robert J | Chairman, Pres & CEO | Buy | 4,200 | $1.77 | $7.4K | 23,649 |
| May 21, 2025 | Ferrara Robert L | Director | Buy | 2,500 | $1.82 | $4.5K | 13,166 |
| Jun 11, 2024 | Bitterman Robert J | President & CEO | Buy | 1,000 | $0.74 | $740.00 | 20,990 |
| Jun 10, 2024 | Bitterman Robert J | President & CEO | Buy | 1,000 | $0.75 | $750.00 | 19,990 |
| Feb 27, 2024 | Bitterman Robert J | President & CEO | Buy | 2,500 | $0.91 | $2.3K | 18,990 |
| Jul 5, 2023 | Bitterman Robert J | President & CEO | Buy | 2,000 | $2.86 | $5.7K | 19,211 |
| Jun 15, 2023 | Ferrara Robert L | Director | Buy | 2,000 | $3.10 | $6.2K | 6,000+50% |
| Dec 15, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.39 | $780.00 | 74,541 |
| Dec 8, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.39 | $780.00 | 72,541 |
| Dec 6, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.43 | $860.00 | 70,541 |
| Dec 5, 2022 | Ferrara Robert L | Director | Buy | 5,000 | $0.41 | $2.0K | 30,000 |
| Nov 29, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,715 | $0.42 | $1.1K | 68,541 |
| Nov 28, 2022 | Ferrara Robert L | Director | Buy | 2,000 | $0.41 | $819.80 | 25,000 |
| Aug 17, 2021 | Dispersyn Gerrit | President & CEO | Buy | 6,000 | $1.63 | $9.8K | 95,281 |
| Mar 5, 2021 | Dispersyn Gerrit | President & CEO | Buy | 1,953 | $2.56 | $5.0K | 89,281 |
| Mar 3, 2021 | Dispersyn Gerrit | President & CEO | Buy | 2,500 | $3.03 | $7.6K | 87,328 |
| Mar 3, 2021 | Ferrara Robert L | Director | Buy | 682 | $3.15 | $2.1K | 13,000 |
PHIO Insider Selling Activity
The following table shows recent insider sales of Phio Pharmaceuticals Corp. (PHIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Bitterman Robert J | Chairman, Pres. & CEO | Sell | 4,111 | $2.32 | $9.5K | 0 |
PHIO Insiders
Similar Stocks to PHIO
VRTX
Vertex Pharmaceuticals Incorporated
$536.14-0.42%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$948.88-0.62%
$99.23B
MRNA
Moderna, Inc.
$214.97-3.55%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.45-3.42%
$39.08B
INSM
Insmed Incorporated
$122.96+1.38%
$26.58B
UTHR
United Therapeutics Corporation
$585.50-0.96%
$25.18B
INCY
Incyte Corporation
$120.12-0.66%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.51-3.31%
$21.41B